Related references
Note: Only part of the references are listed.Assessment of efficacy and safety of volanesorsen for treatment of metabolic complications in patients with familial partial lipodystrophy: Results of the BROADEN study
Elif A. Oral et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2022)
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
J. L. Witztum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Metreleptin-mediated improvements in insulin sensitivity are independent of food intake in humans with lipodystrophy
Rebecca J. Brown et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Genetics of Lipodystrophy
Marissa Lightbourne et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2017)
Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes
Andres Digenio et al.
DIABETES CARE (2016)
Effect of Leptin Administration on Circulating Apolipoprotein CIII levels in Patients With Lipodystrophy
Andrea Kassai et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline
Rebecca J. Brown et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors
Philip L. S. M. Gordts et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Partial and Generalized Lipodystrophy: Comparison of Baseline Characteristics and Response to Metreleptin
Talia Diker-Cohen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia
Daniel Gaudet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes
Karin Avall et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
Anders Berg Jorgensen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Targeting APOC3 in the Familial Chylomicronemia Syndrome
Daniel Gaudet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Liver Metabolite Concentrations Measured with 1H MR Spectroscopy
Ronald Ouwerkerk et al.
RADIOLOGY (2012)
Lipodystrophies: Genetic and Acquired Body Fat Disorders
Abhimanyu Garg
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
M. Herdman et al.
QUALITY OF LIFE RESEARCH (2011)
Metabolism of Very-Low-Density Lipoprotein and Low-Density Lipoprotein Containing Apolipoprotein C-III and Not Other Small Apolipoproteins
Carlos O. Mendivil et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Impact of Combined Deficiency of Hepatic Lipase and Endothelial Lipase on the Metabolism of Both High-Density Lipoproteins and Apolipoprotein B-Containing Lipoproteins
Robert J. Brown et al.
CIRCULATION RESEARCH (2010)
CLINICAL CLASSIFICATION AND TREATMENT OF CONGENITAL AND ACQUIRED LIPODYSTROPHY
Jean L. Chan et al.
ENDOCRINE PRACTICE (2010)
Apolipoprotein C3 Gene Variants in Nonalcoholic Fatty Liver Disease
Kitt Falk Petersen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Apolipoprotein C-III: understanding an emerging cardiovascular risk factor
Esther M. M. Ooi et al.
CLINICAL SCIENCE (2008)
An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?
D. C. Chan et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
Toni I. Pollin et al.
SCIENCE (2008)
Exercise training, without weight loss, increases insulin sensitivity and postheparin plasma lipase activity in previously sedentary adults
GE Duncan et al.
DIABETES CARE (2003)
Contribution of apo CIII reduction to the greater effect of 12-week micronized fenofibrate than atorvastatin therapy on triglyceride levels and LDL size in dyslipidemic patients
I Lemieux et al.
ANNALS OF MEDICINE (2003)
Development of an ultrasensitive noncompetitive hybridization-ligation enzyme-linked immunosorbent assay for the determination of phosphorothioate oligodeoxynucleotide in plasma
RZ Yu et al.
ANALYTICAL BIOCHEMISTRY (2002)
Multisystem dystrophy syndrome due to novel missense mutations in the amino-terminal head and alpha-helical rod domains of the lamin A/C gene
A Garg et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Share Paper
